Trulieve Cannabis Corp. TRLV
11.56 USD +0.66 (+6.06%)
At closeNov 9, 2026, 5:59 AM EST
11.34 -0.22 -1.90%
Pre-market · Nov 9, 5:59 AM ET
10.77 Day range 11.65
4.62 52-week range 13.28
- YTD
- +33.03%
- 1 year
- +76.49%
News
benzinga.com Trulieve Cannabis Q3 Adj. EPS $0.09 Beats $0.05 Estimate, Sales $230.000M Beat $218.321M Estimate Trulieve Cannabis (NYSE:TRLV) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $0.05 by 80 percent. The company reported quarterly sales of $230.000 million…
prnewswire.com Trulieve Reports Third Quarter 2026 Results Third quarter revenue of $230 million, with 64% gross margin Cash flow from operations of $183 million and free cash flow of $120 million* in first nine months of 2026 Received final DEA…
benzinga.com Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target Cantor Fitzgerald analyst Gabie Ingoglia reiterates Trulieve Cannabis (NYSE:TRLV) with a Overweight and maintains $15 price target.- benzinga.com Trulieve Cannabis Awarded Registrations For Medical Marijuana Dispensaries From U.S. Drug Enforcement Administration Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that Trulieve has received registrations for…
prnewswire.com Trulieve Receives DEA Registrations for State-Licensed Medical Marijuana Operations TALLAHASSEE, Fla., Nov. 2, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced…
benzinga.com Deckers Outdoor Posts Mixed Q2 Results, Joins BayCom, Five Point Holdings And Other Big Stocks Moving Lower In Friday’s Pre-Market Session U.S. stock futures fell, led by Deckers down 9% after mixed results and reduced FY27 guidance. BayCom, ROLR, Trulieve and others also slid premarket.
benzinga.com Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target Cantor Fitzgerald analyst Gabie Ingoglia reiterates Trulieve Cannabis (NYSE:TRLV) with a Overweight and maintains $15 price target.
benzinga.com Full Transcript: Trulieve Cannabis Q2 2026 Earnings Call On Friday, Trulieve Cannabis (NYSE:TRLV) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For…